FDA Approved: GRANISETRON HYDROCHLORIDE — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved a supplemental application for granisetron hydrochloride by Mylan Institutional LLC under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Postoperative Nausea and Vomiting

Drugs mentioned

• Granisetron hydrochloride (granisetron hydrochloride)

Snippet

SUPPL AP for GRANISETRON HYDROCHLORIDE (GRANISETRON HYDROCHLORIDE)